Key facts
- This page summarizes Stuart Walter Peltz's Form 4 filing for PTC THERAPEUTICS, INC. (PTCT).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 09 Jan 2023, 15:51.
Stuart Walter Peltz - 05 Jan 2023 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)
- Reporting relationship
- CHIEF EXECUTIVE OFFICER, Director
- Issuer ticker
- PTCT
- Reported as of
- 05 Jan 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Jan 2023, 15:51:56 UTC
- Prior SEC filing
- 09 Jun 2022
- Next SEC filing
- 11 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Avraham S. Adler, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Stuart Walter Peltz filed Form 4 for PTC THERAPEUTICS, INC. (PTCT) on 09 Jan 2023.
Change
- Previous filing in this sequence was filed on 09 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PTCT
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +53,000
- Change %
- +44%
- Price
- $0.000000
- Shares after
- 173,485
- Date
- 05 Jan 2023
- Ownership
- Direct
- Footnotes
- F1
PTCT
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +18,000
- Change %
- +46%
- Price
- $0.000000
- Shares after
- 56,830
- Date
- 05 Jan 2023
- Ownership
- By Spouse
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PTCT
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +132,500
- Change %
- Price
- $0.000000
- Shares after
- 132,500
- Date
- 05 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 132,500
- Exercise price
- $39.42
- Footnotes
- F3
PTCT
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +45,000
- Change %
- Price
- $0.000000
- Shares after
- 45,000
- Date
- 05 Jan 2023
- Ownership
- By Spouse
- Underlying class
- Common Stock
- Underlying amount
- 45,000
- Exercise price
- $39.42
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Restricted stock units granted on January 5, 2023 that vest in four equal installments over four years, commencing on January 5, 2024.
Footnote F2
Includes 293 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2022 and 298 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2022.
Footnote F3
This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024.